🚀 VC round data is live in beta, check it out!
Benitec Biopharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Benitec Biopharma and similar public comparables like Absci, Nextbiomedical Co, PureTech Health, Tanvex BioPharma and more.
Benitec Biopharma Overview
About Benitec Biopharma
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
Founded
2019
HQ
Employees
19
Website
Financials (LTM)
EV
$213M
Benitec Biopharma Financials
Benitec Biopharma reported last 12-month revenue of —.
In the same LTM period, Benitec Biopharma generated had net loss of ($44M).
Revenue (LTM)
Benitec Biopharma P&L
In the most recent fiscal year, Benitec Biopharma reported revenue of — and EBITDA of ($41M).
Benitec Biopharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($41M) | XXX | XXX | XXX |
| Net Profit | ($44M) | XXX | ($38M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Benitec Biopharma Stock Performance
Benitec Biopharma has current market cap of $401M, and enterprise value of $213M.
Market Cap Evolution
Benitec Biopharma's stock price is $11.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $213M | $401M | 8.2% | XXX | XXX | XXX | $-1.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBenitec Biopharma Valuation Multiples
Benitec Biopharma trades at (5.2x) EV/EBITDA.
EV / Revenue (LTM)
Benitec Biopharma Financial Valuation Multiples
As of March 21, 2026, Benitec Biopharma has market cap of $401M and EV of $213M.
Equity research analysts estimate Benitec Biopharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Benitec Biopharma has a P/E ratio of (9.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $401M | XXX | $401M | XXX | XXX | XXX |
| EV (current) | $213M | XXX | $213M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.2x) | XXX | XXX | XXX |
| EV/EBIT | (4.4x) | XXX | (5.1x) | XXX | XXX | XXX |
| P/E | (9.0x) | XXX | (10.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (9.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Benitec Biopharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Benitec Biopharma Margins & Growth Rates
Benitec Biopharma's revenue in the last fiscal year declined by (100%).
Benitec Biopharma's revenue per employee in the last FY averaged $0.0M.
Benitec Biopharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 30% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benitec Biopharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Absci | XXX | XXX | XXX | XXX | XXX | XXX |
| Nextbiomedical Co | XXX | XXX | XXX | XXX | XXX | XXX |
| PureTech Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Tanvex BioPharma | XXX | XXX | XXX | XXX | XXX | XXX |
| DiaMedica | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Benitec Biopharma M&A Activity
Benitec Biopharma acquired XXX companies to date.
Last acquisition by Benitec Biopharma was on XXXXXXXX, XXXXX. Benitec Biopharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Benitec Biopharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBenitec Biopharma Investment Activity
Benitec Biopharma invested in XXX companies to date.
Benitec Biopharma made its latest investment on XXXXXXXX, XXXXX. Benitec Biopharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Benitec Biopharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Benitec Biopharma
| When was Benitec Biopharma founded? | Benitec Biopharma was founded in 2019. |
| Where is Benitec Biopharma headquartered? | Benitec Biopharma is headquartered in United States. |
| How many employees does Benitec Biopharma have? | As of today, Benitec Biopharma has over 19 employees. |
| Who is the CEO of Benitec Biopharma? | Benitec Biopharma's CEO is Jerel A. Banks. |
| Is Benitec Biopharma publicly listed? | Yes, Benitec Biopharma is a public company listed on Nasdaq. |
| What is the stock symbol of Benitec Biopharma? | Benitec Biopharma trades under BNTC ticker. |
| When did Benitec Biopharma go public? | Benitec Biopharma went public in 2012. |
| Who are competitors of Benitec Biopharma? | Benitec Biopharma main competitors are Absci, Nextbiomedical Co, PureTech Health, Tanvex BioPharma. |
| What is the current market cap of Benitec Biopharma? | Benitec Biopharma's current market cap is $401M. |
| Is Benitec Biopharma profitable? | No, Benitec Biopharma is not profitable. |
| What is the current net income of Benitec Biopharma? | Benitec Biopharma's last 12 months net income is ($44M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.